Because dietary acid increases renal secretion of endothelin-1 (ET-1) which is synthesized by renal microvascular endothelium, we examined if reduced extracellular pH increases ET-1 secretion by cultured human renal microvascular endothelial cells (RMVECs). Confluent cells were exposed to serum-free media for 24 h, then incubated in either control, acid, or alkaline serum-free media for 12 h. Standard growth media pH was 7.2 after equilibration with 5% CO2 at 37 degrees C and was made the pH of control media. Acid and alkaline media pH were 7.0 and 7.4, respectively. Added Hepes and Tris maintained all assigned pHs. Media ET-1 measured by RIA after column extraction was higher for RMVECs exposed to acid compared with control media (170.0+/-17.1 vs. 64.6+/-9.6 pM, P < 0.004) but those exposed to alkaline media (56.6+/-25.1 pM, P = NS vs. control) were not. Human aortic endothelial cells exposed to control, acid, and alkaline media had similar ET-1 (166.6+/-18.1, 139.3+/-18.5, and 205.9+/-25.3 pM, P = NS). The data show acid-stimulated ET-1 secretion by RMVECs but not aortic endothelial cells, demonstrating a new environmental factor that influences ET-1 secretion by renal microvascular endothelium and thereby possibly modulates endothelin-dependent processes in vivo.
D E Wesson, J Simoni, D F Green
Title and authors | Publication | Year |
---|---|---|
Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?
Kuhn C, Mohebbi N, Ritter A |
2024 | |
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland, D Grimm, M Infanger, M Krüger |
Journal of Clinical Medicine | 2020 |
Endothelin converting enzyme-1 (ECE-1) deletion in association with Endothelin-1 downregulation ameliorates kidney fibrosis in mice
N Arfian, Y Suzuki, AB Hartopo, N Anggorowati, DA Nugrahaningsih, N Emoto |
Life Sciences | 2020 |
Chronic lithium treatment induces novel patterns of pendrin localization and expression
NJ Himmel, Y Wang, DA Rodriguez, MA Sun, MA Blount |
American journal of physiology. Renal physiology | 2018 |
Metabolic Acidosis
DE Wesson |
2016 | |
Adaptation by the collecting duct to an exogenous acid load is blunted by deletion of the proton-sensing receptor GPR4
X Sun, L Stephens, TD DuBose, S Petrovic |
American journal of physiology. Renal physiology | 2015 |
Comprehensive Physiology
I Kurtz |
Comprehensive Physiology | 2014 |
Potential approaches to reverse or repair renal fibrosis
D Tampe, M Zeisberg |
Nature Reviews Nephrology | 2014 |
Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR
DE Wesson, CH Jo, J Simoni |
Nephrology Dialysis Transplantation | 2014 |
Endothelial Cells Enhance the Migration of Bovine Meniscus Cells: Endothelial Cell Enhancement of Bovine Meniscus Cell Migration
X Yuan, GM Eng, DE Arkonac, PG Chao, G Vunjak-Novakovic |
Arthritis & Rheumatology | 2014 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention
DE Wesson, CH Jo, J Simoni |
Kidney International | 2012 |
Endothelin-1 and the kidney--beyond BP
N Dhaun, DJ Webb, DC Kluth |
British Journal of Pharmacology | 2012 |
Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone
DE Wesson, J Simoni, K Broglio, S Sheather |
American journal of physiology. Renal physiology | 2011 |
Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR
S Phisitkul, A Khanna, J Simoni, K Broglio, S Sheather, MH Rajab, DE Wesson |
Kidney International | 2010 |
Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet
DE Wesson, J Simoni |
Kidney International | 2010 |
CFTR regulation of intracellular pH and ceramides is required for lung endothelial cell apoptosis
J Noe, D Petrusca, N Rush, P Deng, M VanDemark, E Berdyshev, Y Gu, P Smith, K Schweitzer, J Pilewsky, V Natarajan, Z Xu, AG Obukhov, I Petrache |
American journal of respiratory cell and molecular biology | 2009 |
Endothelin receptor selectivity in chronic renal failure
L Longaretti, A Benigni |
European Journal of Clinical Investigation | 2009 |
Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation
H Memetimin, Y Izumi, Y Nakayama, Y Kohda, H Inoue, H Nonoguchi, K Tomita |
American journal of physiology. Renal physiology | 2009 |
Novel Mechanism for Regulation of Endothelin Synthesis: Role of Extracellular pH
PK Stricklett, KA Strait, DE Kohan |
Cellular Physiology and Biochemistry | 2008 |
Vascular Complications in Human Disease
D Abraham, M Dashwood, C Handler, G Coghlan |
2008 | |
Regulation of kidney acid excretion by endothelins
DE Wesson |
Kidney International | 2006 |
Endothelin Role in Kidney Acidification
DE Wesson |
Seminars in Nephrology | 2006 |
Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
DS O'Callaghan, SP Gaine |
International Journal of Clinical Practice | 2006 |
Endothelin and nitric oxide mediate adaptation of the cortical collecting duct to metabolic acidosis
S Tsuruoka, S Watanabe, JM Purkerson, A Fujimura, GJ Schwartz |
American journal of physiology. Renal physiology | 2006 |
Increased endothelin activity mediates augmented distal nephron acidification induced by dietary protein
A Khanna, J Simoni, C Hacker, MJ Duran, DE Wesson |
Transactions of the American Clinical and Climatological Association | 2005 |
Acid-Base Disorders and Their Treatment
L Hamm |
Acid-Base Disorders and Their Treatment | 2005 |
Regulatory and functional interaction of vasoactive factors in the kidney and extracellular pH
SS Prabhakar |
Kidney International | 2004 |
Acid sensing in renal epithelial cells
SL Gluck |
Journal of Clinical Investigation | 2004 |
Endothelin and pulmonary arterial hypertension
Y Braun-Moscovici, AM Nahir, A Balbir-Gurman |
Seminars in Arthritis and Rheumatism | 2004 |
Renal Vacuolar H + -ATPase
CA Wagner, KE Finberg, S Breton, V Marshansky, D Brown, JP Geibel |
Physiological reviews | 2004 |
Heterogeneity in the Effect of Albumin and Other Resuscitation Fluids on Intracellular Oxygen Free Radical Production:
CO Simpkins, D Little, A Brenner, JA Hill, JA Griswold |
The Journal of trauma | 2004 |
TERMINALDIFFERENTIATION OFINTERCALATEDCELLS: The Role of Hensin
Q Al-Awqati |
Annual Review of Physiology | 2003 |
Endothelin, hypercholesterolemia and atherosclerosis
M Barton, T Traupe, CC Haudenschild |
Coronary Artery Disease | 2003 |
T ERMINAL D IFFERENTIATION OF I NTERCALATED C ELLS : The Role of Hensin
Q Al-Awqati |
Annual Review of Physiology | 2003 |
Endothelin A Receptor Blockade and Endothelin B Receptor Blockade Improve Hypokalemic Nephropathy by Different Mechanisms
S Suga, N Yasui, F Yoshihara, T Horio, Y Kawano, K Kangawa, RJ Johnson |
Journal of the American Society of Nephrology : JASN | 2003 |
Inhibition of mesangial iNOS by reduced extracellular pH is associated with uncoupling of NADPH oxidation
SS Prabhakar |
Kidney International | 2002 |
Endothelin-1 and Endothelin Receptor Antagonists as Potential Cardiovascular Therapeutic Agents
A Ergul |
Pharmacotherapy | 2002 |
Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension
RG Tilton, TA Brock, RA Dixon |
Expert Opinion on Investigational Drugs | 2001 |
Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics
M Barton |
Current Hypertension Reports | 2000 |
Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation
S Bachmann-Brandt, I Bittner, P Neuhaus, U Frei, R Schindler |
Transplant International | 2000 |
Physiologic and pathophysiologic renal consequences of H+ -Stimulated endothelin secretion
DE Wesson |
American Journal of Kidney Diseases | 2000 |
Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs
TF Lüscher, M Barton |
Circulation | 2000 |
Endothelin antagonists for hypertension and renal disease
M Barton, TF Luscher |
Current Opinion in Nephrology and Hypertension | 1999 |
Volume Stress-Induced Peritoneal Endothelin-1 Release in Continuous Ambulatory Peritoneal Dialysis
S Morgera, S Kuchinke, K Budde, A Lun, B Hocher, HH Neumayer |
Journal of the American Society of Nephrology : JASN | 1999 |
Letter to the editor
MA Gillman, FJ Lightigfeld |
PAIN | 1981 |